AI English summary of an SEC filing — figures as filed
Boston Scientific BSXBoston Scientific said stockholders at its April 30, 2026 Annual Meeting of Stockholders approved amendments to the Company's Third Restated Certificate of Incorporation to eliminate supermajority voting provisions and to provide for exculpation of certain officers. The amendments became effective upon the filing of the Fourth Restated Certificate of Incorporation with the Secretary of State of Delaware on May 5, 2026.
Key points
AI summaryBoston Scientific said stockholders at its April 30, 2026 Annual Meeting of Stockholders approved amendments to the Company's Third Restated Certificate of Incorporation to eliminate supermajority voting provisions and to provide for exculpation of certain officers. The amendments became effective upon the filing of the Fourth Restated Certificate of Incorporation with the Secretary of State of Delaware on May 5, 2026.
The company said all 10 director nominees were elected to the Board for a 1-year term. David C. Habiger received 1,037,805,652 votes for and 169,730,106 votes against, while Christophe P. Weber received 1,205,365,637 votes for and 2,260,256 votes against.
Boston Scientific said the amendment to remove supermajority voting provisions was approved with 1,189,271,431 votes for and 17,774,053 votes against. The amendment to provide for exculpation of certain officers was approved with 1,057,086,923 votes for and 150,458,633 votes against.
The company said the amendment to the Third Restated Certificate of Incorporation and Amended and Restated By-Laws to permit stockholders owning not less than 25% of the Company's common stock to call a special meeting of stockholders was not approved. A stockholder proposal titled "Give Shareholders the Ability to Call for a Special Shareholder Meeting" was also not approved, receiving 516,140,863 votes for and 689,739,605 votes against.
Summary
AI-writtenAnalysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Charter Amendments Approved and Effective
Boston Scientific said stockholders at its April 30, 2026 Annual Meeting of Stockholders approved amendments to the Company's Third Restated Certificate of Incorporation to eliminate supermajority voting provisions and to provide for exculpation of certain officers. The amendments became effective upon the filing of the Fourth Restated Certificate of Incorporation with the Secretary of State of Delaware on May 5, 2026.
Source · Based on the filing body and exhibits
All 10 Director Nominees Elected
The company said all 10 director nominees were elected to the Board for a 1-year term. David C. Habiger received 1,037,805,652 votes for and 169,730,106 votes against, while Christophe P. Weber received 1,205,365,637 votes for and 2,260,256 votes against.
Source · Based on the filing body and exhibits
Supermajority Voting Provisions Removed and Officer Exculpation Amendment Approved
Boston Scientific said the amendment to remove supermajority voting provisions was approved with 1,189,271,431 votes for and 17,774,053 votes against. The amendment to provide for exculpation of certain officers was approved with 1,057,086,923 votes for and 150,458,633 votes against.
Source · Based on the filing body and exhibits
Two Proposals on Special Meeting Rights Not Approved
The company said the amendment to the Third Restated Certificate of Incorporation and Amended and Restated By-Laws to permit stockholders owning not less than 25% of the Company's common stock to call a special meeting of stockholders was not approved. A stockholder proposal titled "Give Shareholders the Ability to Call for a Special Shareholder Meeting" was also not approved, receiving 516,140,863 votes for and 689,739,605 votes against.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…